Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma.
J Clin Oncol. 2021 Sep 10;39(26):2914-2925. doi: 10.1200/JCO.21.00675. Epub 2021 Jul 13.
J Clin Oncol. 2021.
PMID: 34255535
Clinical Trial.